Table 2.
Evaluation after 1st cycle patient n (%) | Final results patient n (%) | |
CR | 1 (3.6) | |
PR | 16 (57.1) | 5 (17.9) |
NR | 12 (42.9) | 22 (78.6) |
IFN, interferon; FU, fluorouracil; CR, complete response; PR, partial response; NR, no response.
Evaluation after 1st cycle patient n (%) | Final results patient n (%) | |
CR | 1 (3.6) | |
PR | 16 (57.1) | 5 (17.9) |
NR | 12 (42.9) | 22 (78.6) |
IFN, interferon; FU, fluorouracil; CR, complete response; PR, partial response; NR, no response.